Prognostic Value of Skeletal Muscle Depletion Measured on Computed Tomography for Overall Survival in Patients with Non-Metastatic Breast Cancer

被引:16
作者
Huh, Jimi [1 ]
Park, Bumhee [2 ]
Lee, Heirim [2 ]
An, Young-Sil [3 ]
Jung, Yongsik [4 ]
Kim, Ji Young [4 ]
Kang, Doo Kyoung [1 ]
Kim, Kyung Won [5 ]
Kim, Tae Hee [1 ]
机构
[1] Ajou Univ, Dept Radiol, Sch Med, 164 World Cup Ro, Suwon 16499, South Korea
[2] Ajou Univ, Dept Biomed Informat, Sch Med, Suwon, South Korea
[3] Ajou Univ, Dept Nucl Med & Mol Imaging, Sch Med, Suwon, South Korea
[4] Ajou Univ, Dept Surg, Sch Med, Suwon, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Suwon, South Korea
基金
新加坡国家研究基金会;
关键词
Breast; Carcinoma; Sarcopenia; Survival; BODY-COMPOSITION; SARCOPENIA; METAANALYSIS; STATISTICS; DIAGNOSIS; TOXICITY; EFFICACY;
D O I
10.4048/jbc.2020.23.e8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this study was to evaluate the prognostic value of skeletal muscle depletion measured on computed tomography (CT) in patients with non-metastatic invasive breast cancer. Methods: This retrospective study included 577 consecutive women (mean age +/- standard deviation: 48.9 +/- 10.2 years with breast cancer who underwent a preoperative positron-emission tomography (PET)/CT scan and curative surgery between January 2012 and August 2014. The total abdominal muscle area (TAMA), subcutaneous fat area (SFA), and visceral fat area (VFA) were measured on CT images at the L3 vertebral level. Univariate and multivariate Cox proportional-hazard regression analyses were performed to evaluate whether there was an association between sarcopenia and overall survival (OS) outcome. Results: Of the 577 women, 49 (8.5%) died after a mean of 46 months. The best TAMA threshold for predicting OS was 83.7 cm(2). The multivariate Cox proportional-hazard analysis revealed that sarcopenia (TAMA <= 83.70 cm(2)) was a strong prognostic biomarker (hazard ratio [HR], 1.951; 95% confidence interval [CI], 1.061-3.586), along with large tumor size, axillary lymph node metastasis, high nuclear grade, estrogen receptor status, and adjuvant radiation therapy. In the subgroup analysis of patients aged >= 50 years, TAMA (<= 77.14 cm(2)) was a significant independent factor (HR, 2.856; 95% CI, 1.218-6.695). Conclusion: Skeletal muscle depletion measured on CT was associated with worse OS outcome in patients with non-metastatic breast cancer.
引用
收藏
页码:80 / 92
页数:13
相关论文
共 30 条
[1]   THE RELATION BETWEEN SURVIVAL AND AGE AT DIAGNOSIS IN BREAST-CANCER [J].
ADAMI, HO ;
MALKER, B ;
HOLMBERG, L ;
PERSSON, I ;
STONE, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (09) :559-563
[2]   Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials [J].
Albain, K. ;
Anderson, S. ;
Arriagada, R. ;
Barlow, W. ;
Bergh, J. ;
Bliss, J. ;
Buyse, M. ;
Cameron, D. ;
Carrasco, E. ;
Clarke, M. ;
Correa, C. ;
Coates, A. ;
Collins, R. ;
Costantino, J. ;
Cutter, D. ;
Cuzick, J. ;
Darby, S. ;
Davidson, N. ;
Davies, C. ;
Davies, K. ;
Delmestri, A. ;
Di Leo, A. ;
Dowsett, M. ;
Elphinstone, P. ;
Evans, V. ;
Ewertz, M. ;
Gelber, R. ;
Gettins, L. ;
Geyer, C. ;
Goldhirsch, A. ;
Godwin, J. ;
Gray, R. ;
Gregory, C. ;
Hayes, D. ;
Hill, C. ;
Ingle, J. ;
Jakesz, R. ;
James, S. ;
Kaufmann, M. ;
Kerr, A. ;
MacKinnon, E. ;
McGale, P. ;
McHugh, T. ;
Norton, L. ;
Ohashi, Y. ;
Paik, S. ;
Pan, H. C. ;
Perez, E. ;
Peto, R. ;
Piccart, M. .
LANCET, 2012, 379 (9814) :432-444
[3]   Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review [J].
Aleixo, G. F. P. ;
Williams, G. R. ;
Nyrop, K. A. ;
Muss, H. B. ;
Shachar, S. S. .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 177 (03) :569-579
[4]   A 360-degree overview of body composition in healthy people: Relationships among anthropometry, ultrasonography, and dual-energy x-ray absorptiometry [J].
Bazzocchi, Alberto ;
Diano, Danila ;
Ponti, Federico ;
Salizzoni, Eugenio ;
Albisinni, Ugo ;
Marchesini, Giulio ;
Battista, Giuseppe .
NUTRITION, 2014, 30 (06) :696-701
[5]   Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis [J].
Beaudart, Charlotte ;
Zaaria, Myriam ;
Pasleau, Francoise ;
Reginster, Jean-Yves ;
Bruyere, Olivier .
PLOS ONE, 2017, 12 (01)
[6]  
Caan BJ, 2018, JAMA ONCOL, V4, P798, DOI 10.1001/jamaoncol.2018.0137
[7]   Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers [J].
Chia, Stephen ;
Norris, Brian ;
Speers, Caroline ;
Cheang, Maggie ;
Gilks, Blake ;
Gown, Allen M. ;
Huntsman, David ;
Olivotto, Ivo A. ;
Nielsen, Torsten O. ;
Gelmon, Karen .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) :5697-5704
[8]   Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials [J].
Davies, C. ;
Godwin, J. ;
Gray, R. ;
Clarke, M. ;
Darby, S. ;
McGale, P. ;
Wang, Y. C. ;
Peto, R. ;
Pan, H. C. ;
Cutter, D. ;
Taylor, C. ;
Ingle, J. .
LANCET, 2011, 378 (9793) :771-784
[9]   Breast Cancer Statistics, 2013 [J].
DeSantis, Carol ;
Ma, Jiemin ;
Bryan, Leah ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (01) :52-62
[10]   Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status [J].
Foulkes, William D. ;
Grainge, Matthew J. ;
Rakha, Emad A. ;
Green, Andrew R. ;
Ellis, Ian O. .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (01) :199-204